However, there is little prospect of efficacy with MDM2 inhibitors alone in therapy (70), MDM2 suppression was linked to elevated p53 protein expression in pre-clinical and clinical studies, but it was not linked to an improvement in the results of tumour growth suppression or prolonged survival (71). The gene discussed is MDM2; the disease is neoplasm.